Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Elevated Platelet Tests Associated with Severe Heart Disease Risks

By LabMedica International staff writers
Posted on 13 Apr 2016
As a major component of the blood-vascular axis responsible for preventing hemorrhage, platelets (PLT) are crucial in the development of ischemic stroke due to its participation in thromboemboli that may initiate the symptoms of stroke.

Mean platelet volume (MPV) and PLT count are the two major parameters that reflect the functions and activities of PLTs. MPV, which describes the mean volume (size) of platelets, is an indicator that represents megakaryocytic hyperplasia and metabolism, and platelet production in bone marrow, and indicates the age of circulating platelets.

Scientists at Sichuan University (Chengdu, China) studied 281 first-time ischemic stroke and 164 first-time hemorrhagic stroke patients between 2010 and 2012. All participants received routine blood tests within two hours after admission and were categorized into good or poor prognosis group based on the Modified Rankin Scale (mRS) score. MPV and PLT count were measured within 30 minutes after venipuncture with a Sysmex XS-2000i autoanalyzer (Sysmex Corporation; Kobe, Japan).

The investigators found that the risk of ischemic and hemorrhagic stroke in MPV group of greater than 13 fL was 22.17 and 5.21 times higher compared with normal MPV group (9.4–12.5 fL). The PLT count was positively correlated with the risk of ischemic stroke, but negatively correlated with the risk of hemorrhagic stroke. MPV and PLT count was not correlated with the prognosis of either stroke. The findings showed that a decline in MPV reduced the risk of ischemic stroke whereas an elevated MPV increased the risk of ischemic stroke.

The authors concluded that increased MPV is an independent risk factor for both strokes. Elevated PLT count increases the risk for ischemic stroke, but decreases the risk for hemorrhagic stroke. However, neither MPV nor PLT count has significant association with the prognosis of either stroke. The study was published on March 19, 2016, in the International Journal of Laboratory Hematology.

Related Links:

Sichuan University 
Sysmex Corporation 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.